BioRestorative Therapies (BRTX) Times Interest Earned (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly Times Interest Earned came in at -$0.17 in Q4 2025, up 99.73% YoY from -$0.08 in Q4 2024, and up 98.1% on a QoQ basis from -$8.94 in Q2 2025.
BioRestorative Therapies (BRTX) Times Interest Earned (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 16 years of Times Interest Earned data on file, last reported at -$0.17 in Q4 2025.
- Quarterly Times Interest Earned rose 99.73% year-over-year to -$0.17 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.69 (up 98.99% YoY) and the FY2025 annual result came in at -$0.69, down 76.48% from the prior year.
- Times Interest Earned rose to -$0.17 in Q4 2025, from -$8.94 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.17 in Q4 2025 to a low of -$2687.4 in Q3 2024.
- A 5-year average of -$267.39 and a median of -$93.85 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2021 — Times Interest Earned slumped 16708.62% — and 2025, when it surged 99.73%.
- Tracing BRTX's Times Interest Earned over 5 years: stood at -$101.26 in 2021, then slipped by 13.37% to -$114.8 in 2022, then soared by 33.21% to -$76.67 in 2023, then increased by 18.9% to -$62.18 in 2024, then jumped by 99.73% to -$0.17 in 2025.
- The last three Times Interest Earned figures came in at -$0.17 (Q4 2025), -$8.94 (Q2 2025), and -$8.49 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.17 |
| Jun 30, 2025 | -8.94 |
| Mar 31, 2025 | -8.49 |
| Dec 31, 2024 | -62.18 |
| Sep 30, 2024 | -2,687.42 |
| Jun 30, 2024 | -836.88 |
| Mar 31, 2024 | -31.66 |
| Dec 31, 2023 | -76.67 |
| Sep 30, 2023 | -189.96 |
| Jun 30, 2023 | -135.42 |
| Mar 31, 2023 | -137.57 |
| Dec 31, 2022 | -114.80 |
| Sep 30, 2022 | -93.85 |
| Jun 30, 2022 | -77.52 |
| Mar 31, 2022 | -123.92 |
| Dec 31, 2021 | -101.26 |
| Sep 30, 2021 | -7.44 |
| Jun 30, 2021 | -6.09 |
| Mar 31, 2021 | -380.24 |
| Dec 31, 2020 | -3.37 |